1. Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
- Author
-
Molina-Jijón E, Rodríguez-Muñoz R, González-Ramírez R, Namorado-Tónix C, Pedraza-Chaverri J, and Reyes JL
- Subjects
- Animals, Diabetes Mellitus, Experimental blood, Diabetes Mellitus, Experimental complications, Diabetes Mellitus, Experimental pathology, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 complications, Diabetes Mellitus, Type 1 pathology, Female, Hyperglycemia blood, Hyperglycemia drug therapy, Hyperglycemia prevention & control, Immediate-Early Proteins metabolism, Kidney Glomerulus drug effects, Kidney Glomerulus pathology, Kidney Tubules drug effects, Kidney Tubules pathology, Models, Biological, Natriuresis drug effects, Oxidative Stress drug effects, Phosphorylation drug effects, Potassium blood, Protein Serine-Threonine Kinases metabolism, Proteinuria blood, Proteinuria complications, Proteinuria drug therapy, Proteinuria prevention & control, Rats, Wistar, Spironolactone pharmacology, Spironolactone therapeutic use, Tight Junctions drug effects, Tight Junctions metabolism, Weight Loss drug effects, Aldosterone metabolism, Claudin-4 metabolism, Claudins metabolism, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Type 1 metabolism, Nephrons metabolism, Signal Transduction drug effects
- Abstract
Hyperglycemia in diabetes alters tight junction (TJ) proteins in the kidney. We evaluated the participation of aldosterone (ALD), and the effect of spironolactone (SPL), a mineralocorticoid receptor antagonist, on the expressions of claudin-2, -4, -5 and -8, and occludin in glomeruli, proximal and distal tubules isolated from diabetic rats. Type 1 diabetes was induced in female Wistar rats by a single tail vein injection of streptozotocin (STZ), and SPL was administrated daily by gavage, from days 3-21. Twenty-one days after STZ injection the rats were sacrificed. In diabetic rats, the serum ALD levels were increased, and SPL-treatment did not have effect on these levels or in hyperglycemia, however, proteinuria decreased in SPL-treated diabetic rats. Glomerular damage, evaluated by nephrin and Wilm's tumor 1 (WT1) protein expressions, and proximal tubular damage, evaluated by kidney injury molecule 1 (Kim-1) and heat shock protein 72 kDa (Hsp72) expressions, were ameliorated by SPL. Also, SPL prevented decrement in claudin-5 in glomeruli, and claudin-2 and occludin in proximal tubules by decreasing oxidative stress, evaluated by superoxide anion (O2●-) production, and oxidative stress markers. In distal tubules, SPL ameliorated increase in mRNA, protein expression, and phosphorylation in threonine residues of claudin-4 and -8, through a serum and glucocorticoid-induced kinase 1 (SGK1), and with-no-lysine kinase 4 (WNK4) signaling pathway. In conclusion, this is the first study that demonstrates that ALD modulates the expression of renal TJ proteins in diabetes, and that the blockade of its actions with SPL, may be a promising therapeutic strategy to prevent alterations of TJ proteins in diabetic nephropathy.
- Published
- 2017
- Full Text
- View/download PDF